Comparison of prognostic value of different MRI classifications of signal intensity change in cervical spondylotic myelopathy
To access this article, please choose from the options below
FDA device/drug status: not applicable.
Author disclosures: none.
PII: S1529-9430(10)00216-0
doi:10.1016/j.spinee.2010.03.024
© 2010 Elsevier Inc. All rights reserved.
